SEC Form 4 reporting owner

Herskowitz Neil

Herskowitz Neil has filed 3 Form 4 transactions reported between December 30, 2025 and July 1, 2026, as Director of Journey Medical Corp and Director of MUSTANG BIO, INC..

Name as filed: Herskowitz Neil

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$238
1 lines
Companies
2
with Form 4 filings
Latest transaction
Jul 1, 2026
transaction date

Roles and reported holdings

  • DERMJourney Medical Corp
    Jun 25, 2026 – Jul 1, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • MBIOMUSTANG BIO, INC.
    Dec 30, 2025

    Director

    Held directly145 sh as of Dec 30, 2025 · Form 4

    24 months: $238 sold

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 1, 2026DERMDirectorGrant or awardCode A · direct50,000—Form 4
Jun 25, 2026DERMDirectorGrant or awardCode A · direct10,000—Form 4
Dec 30, 2025MBIODirectorOpen-market saleCode S · directAlso reported by Jin David247$238@ $0.9620Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.